Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for point of care diagnostics by component
5.1 Hardware
5.1.1 Market size and forecast
5.2 Software
5.2.1 Market size and forecast

Part 6. Global market for point of care diagnostics by product
6.1 Alcohol & drug abuse
6.1.1 Market size and forecast
6.2 Blood gas & electrolyte
6.2.1 Market size and forecast
6.3 Cardiac markers
6.3.1 Market size and forecast
6.4 Cholesterol
6.4.1 Market size and forecast
6.5 Glucose monitoring
6.5.1 Market size and forecast
6.6 Hemoglobin & hemostasis
6.6.1 Market size and forecast
6.7 Infectious disease
6.7.1 Market size and forecast
6.8 Pregnancy and fertility
6.8.1 Market size and forecast
6.9 Tumor markers
6.9.1 Market size and forecast
6.10 Urine chemistry
6.10.1 Market size and forecast
6.11 Others
6.11.1 Market size and forecast

Part 7. Global market for point of care diagnostics by end user
7.1 Professional diagnostic centers
7.1.1 Market size and forecast
7.2 Home care
7.2.1 Market size and forecast
7.3 Others
7.3.1 Market size and forecast

Part 8. Global market for point of care diagnostics by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast

Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 Becton, Dickinson and Company
9.3 Chembio Diagnostics, Inc.
9.4 Danaher Corporation
9.5 EKF Diagnostics Holdings plc
9.6 F. Hoffmann-La Roche Ltd.
9.7 Koninklijke Philips N.V.
9.8 Medtronic plc
9.9 Mindray Medical International Limited
9.10 Siemens Healthineers AG
9.11 Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY